294 related articles for article (PubMed ID: 29294089)
1. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis.
Pauling JD; Salazar G; Lu H; Betteridge ZE; Assassi S; Mayes MD; McHugh NJ
Rheumatology (Oxford); 2018 Apr; 57(4):712-717. PubMed ID: 29294089
[TBL] [Abstract][Full Text] [Related]
2. Brief Report: Anti-Eukaryotic Initiation Factor 2B Autoantibodies Are Associated With Interstitial Lung Disease in Patients With Systemic Sclerosis.
Betteridge ZE; Woodhead F; Lu H; Shaddick G; Bunn CC; Denton CP; Abraham DJ; du Bois RM; Lewis M; Wells AU; McHugh NJ
Arthritis Rheumatol; 2016 Nov; 68(11):2778-2783. PubMed ID: 27273608
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to RuvBL1 and RuvBL2: a novel systemic sclerosis-related antibody associated with diffuse cutaneous and skeletal muscle involvement.
Kaji K; Fertig N; Medsger TA; Satoh T; Hoshino K; Hamaguchi Y; Hasegawa M; Lucas M; Schnure A; Ogawa F; Sato S; Takehara K; Fujimoto M; Kuwana M
Arthritis Care Res (Hoboken); 2014 Apr; 66(4):575-84. PubMed ID: 24023044
[TBL] [Abstract][Full Text] [Related]
4. Recognising the spectrum of scleromyositis: HEp-2 ANA patterns allow identification of a novel clinical subset with anti-SMN autoantibodies.
Landon-Cardinal O; Baril-Dionne A; Hoa S; Meyer A; Leclair V; Bourré-Tessier J; Mansour AM; Zarka F; Makhzoum JP; Nehme J; Rich E; Goulet JR; Grodzicky T; Koenig M; Joyal F; Richard I; Hudson M; Targoff I; Satoh M; Fritzler MJ; Troyanov Y; Senécal JL
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32892170
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies as biomarkers for interstitial lung disease in idiopathic inflammatory myositis and systemic sclerosis: The case of anti-eIF2B antibodies.
Ceribelli A; Isailovic N; De Santis M; Gorlino C; Satoh M; Selmi C
J Transl Autoimmun; 2020; 3():100049. PubMed ID: 32743530
[TBL] [Abstract][Full Text] [Related]
6. Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers.
Cavazzana I; Vojinovic T; Airo' P; Fredi M; Ceribelli A; Pedretti E; Lazzaroni MG; Garrafa E; Franceschini F
Clin Rev Allergy Immunol; 2023 Jun; 64(3):412-430. PubMed ID: 35716254
[TBL] [Abstract][Full Text] [Related]
7. A subset of systemic sclerosis but not of systemic lupus erythematosus is defined by isolated anti-Ku autoantibodies.
Cavazzana I; Fredi M; Taraborelli M; Quinzanini M; Tincani A; Franceschini F
Clin Exp Rheumatol; 2013; 31(2 Suppl 76):118-21. PubMed ID: 23910615
[TBL] [Abstract][Full Text] [Related]
8. Reflex testing of speckled cytoplasmic patterns observed in routine ANA HEp-2 indirect immunofluorescence with a multiplex anti-synthetase dot-blot assay: a multicentric pilot study.
Infantino M; Palterer B; Biagiotti R; Almerigogna F; Benucci M; Damiani A; Grossi V; Azzurri A; Casprini P; Bacci G; Giudizi MG; Manfredi M
Immunol Res; 2018 Feb; 66(1):74-78. PubMed ID: 29159696
[TBL] [Abstract][Full Text] [Related]
9. A case of anti-RuvBL1/2 antibody-positive systemic sclerosis overlapping with myositis.
Nomura Y; Ueda-Hayakawa I; Yamazaki F; Ozaki Y; Hamaguchi Y; Takehara K; Okamoto H
Eur J Dermatol; 2020 Feb; 30(1):52-53. PubMed ID: 32031537
[No Abstract] [Full Text] [Related]
10. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests.
Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ;
J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of Japanese systemic sclerosis (SSc) patients negative for SSc-related autoantibodies: A single-center retrospective study.
Miyake M; Matsushita T; Takehara K; Hamaguchi Y
Int J Rheum Dis; 2020 Aug; 23(9):1219-1225. PubMed ID: 32662135
[TBL] [Abstract][Full Text] [Related]
12. Disease-related autoantibody profile in patients with systemic sclerosis.
Liaskos C; Marou E; Simopoulou T; Barmakoudi M; Efthymiou G; Scheper T; Meyer W; Bogdanos DP; Sakkas LI
Autoimmunity; 2017 Nov; 50(7):414-421. PubMed ID: 28749191
[TBL] [Abstract][Full Text] [Related]
13. [Autoantibodies and their clinical characteristics in systemic sclerosis].
Hamaguchi Y
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(3):139-47. PubMed ID: 23812071
[TBL] [Abstract][Full Text] [Related]
14. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features.
Mierau R; Moinzadeh P; Riemekasten G; Melchers I; Meurer M; Reichenberger F; Buslau M; Worm M; Blank N; Hein R; Müller-Ladner U; Kuhn A; Sunderkötter C; Juche A; Pfeiffer C; Fiehn C; Sticherling M; Lehmann P; Stadler R; Schulze-Lohoff E; Seitz C; Foeldvari I; Krieg T; Genth E; Hunzelmann N
Arthritis Res Ther; 2011; 13(5):R172. PubMed ID: 22018289
[TBL] [Abstract][Full Text] [Related]
15. Clinical features of patients with systemic sclerosis positive for anti-SS-A antibody: a cohort study of 156 patients.
Watanabe T; Ototake Y; Akita A; Suzuki M; Kanaoka M; Tamura J; Saigusa Y; Yamaguchi Y
Arthritis Res Ther; 2024 May; 26(1):93. PubMed ID: 38702799
[TBL] [Abstract][Full Text] [Related]
16. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
[TBL] [Abstract][Full Text] [Related]
17. Case of anti-RuvBL1/2 antibody-positive morphea and polymyositis.
Takahashi T; Nakanishi T; Hamaguchi Y; Tanaka T; Fujimoto N
J Dermatol; 2017 Oct; 44(10):1188-1190. PubMed ID: 27786369
[No Abstract] [Full Text] [Related]
18. Prevalence and clinical profiles of 'autoantibody-negative' systemic sclerosis subjects.
Hudson M; Satoh M; Chan JY; Tatibouet S; Mehra S; Baron M; Fritzler M;
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-127-32. PubMed ID: 24144389
[TBL] [Abstract][Full Text] [Related]
19. Specific anti-nuclear antibodies in systemic sclerosis patients with and without skin involvement: an extended methodological approach.
Van Praet JT; Van Steendam K; Smith V; De Bruyne G; Mimori T; Bonroy C; Elewaut D; Deforce D; De Keyser F
Rheumatology (Oxford); 2011 Jul; 50(7):1302-9. PubMed ID: 21330340
[TBL] [Abstract][Full Text] [Related]
20. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
